Literature DB >> 7862937

Observational studies of dopamine D1 and D2 agonists in squirrel monkeys.

S Rosenzweig-Lipson1, P Hesterberg, J Bergman.   

Abstract

The behavioral effects of selective D1 and D2, nonselective, and indirectly acting dopamine agonists were compared in squirrel monkeys using continuous observation procedures. D1 agonists including SKF 81297, SKF 82958, and R(+)-6-Br-APB produced dose-dependent increases in the frequencies of stationary postures and head movements and had little or no effect on either huddling or scratching. In contrast, SKF 75670 and R-SKF 38393, which are considered to be D1 partial agonists, had effects comparable to those of the D1 antagonist SCH 39166. That is, the D1 partial agonists increased the duration of huddling without greatly altering the frequencies of stationary postures, head movements, or scratching. Unlike the D1 agonists, the D2 agonists (+)-PHNO, quinpirole, and bromocriptine increased the frequency of scratching, but did not consistently alter other observable behaviors. The indirect dopamine agonists cocaine, GBR 12909, and d-amphetamine and the nonselective D1/D2 agonist CY 208-243, but not (-)apomorphine, had effects comparable to those of D1 agonists such as SKF 81297. That is, each of these drugs increased the frequencies of stationary postures and head movements with little or no effect on scratching or huddling. Additionally, effects of the D1 agonist SKF 82958 and the indirect dopamine agonist cocaine were surmountably antagonized by the D1 antagonist SCH 39166. The present results show that: 1) behavioral effects of D1 and D2 agonists in monkeys are qualitatively different; 2) D1 agonists presumed to differ in intrinsic activity have dissimilar effects; and 3) effects of indirect dopamine agonists are comparable to those of D1 agonists with presumably high intrinsic activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862937     DOI: 10.1007/bf02244865

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  45 in total

1.  Weak antiparkinsonian activity of the D1 agonist C-APB (SKF 82958) and lack of synergism with a D2 agonist in primates.

Authors:  N M Rupniak; S Boyce; M Steventon; S D Iversen
Journal:  Clin Neuropharmacol       Date:  1992-08       Impact factor: 1.592

2.  Cocaine-antagonist effects of limited-efficacy D1 agonists.

Authors:  J Bergman; S Rosenzweig-Lipson
Journal:  NIDA Res Monogr       Date:  1992

3.  Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys.

Authors:  N M Rupniak; S J Tye; C A Jennings; A E Loper; J V Bondi; M Hichens; E Hand; S D Iversen; S M Stahl
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

4.  Behavioural differentiation between effects elicited at dopamine D-1 and D-2 receptors in rats.

Authors:  J Arnt; J Hyttel
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

5.  Pharmacological studies on drugs acting on the social behaviour of the squirrel monkey. Effects of amineptine, piribedil, d-amphetamine, and amitriptyline.

Authors:  J C Poignant; A Avril
Journal:  Arzneimittelforschung       Date:  1978

6.  Induction of oral dyskinesias in naive rats by D1 stimulation.

Authors:  H Rosengarten; J W Schweitzer; A J Friedhoff
Journal:  Life Sci       Date:  1983-12-19       Impact factor: 5.037

7.  Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  d-Amphetamine in squirrel monkeys of different social status: effects on social and agonistic behavior, locomotion, and stereotypies.

Authors:  K A Miczek; L H Gold
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.

Authors:  R Longoni; L Spina; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1987-02-10       Impact factor: 4.432

10.  Interaction of haloperidol and SCH 23390 with cocaine and dopamine receptor subtype-selective agonists on schedule-controlled behavior of squirrel monkeys.

Authors:  J M Witkin; C W Schindler; S R Tella; S R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more
  13 in total

1.  Repetitive behaviors in monkeys are linked to specific striatal activation patterns.

Authors:  Esen Saka; Claudia Goodrich; Patricia Harlan; Bertha K Madras; Ann M Graybiel
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

2.  Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.

Authors:  Jennifer C Felger; Oyetunde Alagbe; Fang Hu; Deborah Mook; Amanda A Freeman; Mar M Sanchez; Ned H Kalin; Emiliangelo Ratti; Charles B Nemeroff; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2007-08-02       Impact factor: 13.382

Review 3.  Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.

Authors:  Jennifer C Felger; Andrew H Miller
Journal:  Front Neuroendocrinol       Date:  2012-09-21       Impact factor: 8.606

Review 4.  Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Authors:  J C Felger; F E Lotrich
Journal:  Neuroscience       Date:  2013-05-03       Impact factor: 3.590

5.  Dynamics and Functional Role of Dopaminergic Neurons in the Ventral Tegmental Area during Itch Processing.

Authors:  Lei Yuan; Tong-Yu Liang; Juan Deng; Yan-Gang Sun
Journal:  J Neurosci       Date:  2018-09-28       Impact factor: 6.167

Review 6.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

7.  Self-administration of D1 receptor agonists by squirrel monkeys.

Authors:  D M Grech; R D Spealman; J Bergman
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

8.  Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation.

Authors:  A V Azaryan; B J Clock; B M Cox
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

9.  Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates.

Authors:  Taline V Khroyan; Donna M Platt; James K Rowlett; Roger D Spealman
Journal:  Psychopharmacology (Berl)       Date:  2003-02-27       Impact factor: 4.530

10.  Behavioural supersensitivity following neonatal 6-hydroxydopamine: attenuation by MK-801.

Authors:  T Archer; Anders Fredriksson
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.